Trading Signals: GWPH Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Tue. May. 4, 2021)(GW Pharmaceuticals plc)
| GWPH latest price $122.7800 (-1.65%) ($120.2500 - $125.8300) on Mon. Dec. 10, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.25% (three month average) | RSI | 38 | Latest Price | $122.7800(-1.65%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | GWPH declines -0.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support GWPH advance at 0% a week (0% probability) IBB(38%) IBUY(38%) IWC(38%) SKYY(38%) IPO(37%) | Factors Impacting GWPH price | GWPH will decline at least -1.625% in a week (0% probabilities). TLT(-24%) VIXM(-12%) UUP(-11%) VXX(-8%) BWX(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.625% (StdDev 3.25%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $126.39 | 5 Day Moving Average | $124.73(-1.56%) | 10 Day Moving Average | $123.98(-0.97%) | 20 Day Moving Average | $126.39(-2.86%) | To recent high | -29.6% | To recent low | 1.3% | Market Cap | $3.824b | | | | GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. |